Endometrial biopsy in the evaluation of infertility

  • Vanderbilt University Medical Center ROR

Fertility and Sterility, 33(2), 121-124

DOI 10.1016/s0015-0282(16)44530-9 PMID 7353687

Abstract

One hundred and forty-nine patients presenting with infertility underwent two hundred and ten endometrial biopsies as part of a routine infertility evaluation. The initial biopsy was out of phase in 44 (29.5%), confirmed by subsequent biopsy to yield a total of 28 (19%) patients with luteal phase inadequacy. Of 44 patients taking clomiphene citrate, 13 (29.5%) had out-of-phase biopsies. Although hyperprolactinemia, recurrent miscarriages, extremes of reproductive life, and clomiphene citrate administration have been associated with an increased incidence of the defect, in this series a predisposing cause could not be detected in approximately one-half of the patients. The routinely obtained endometrial biopsy provides a safe, reproducible, and adequate means of providing histologic evidence for normal endometrial development for subsequent implantation.

Topics

endometrial biopsy infertility evaluation luteal phase defect, Wentz luteal phase inadequacy endometrial biopsy, out of phase endometrial biopsy infertility workup, luteal phase deficiency clomiphene citrate endometrial dating, endometrial biopsy reproducibility implantation assessment, hyperprolactinemia luteal phase defect endometrial biopsy, recurrent miscarriage luteal phase inadequacy histology, clomiphene citrate out of phase endometrial biopsy incidence, endometrial development histologic dating infertility, routine endometrial biopsy infertility evaluation protocol
PMID 7353687 7353687 DOI 10.1016/s0015-0282(16)44530-9 10.1016/s0015-0282(16)44530-9

Cite this article

Wentz, A. C. (1980). Endometrial biopsy in the evaluation of infertility. *Fertility and sterility*, *33*(2), 121-124. https://doi.org/10.1016/s0015-0282(16)44530-9

Related articles